Đang chuẩn bị liên kết để tải về tài liệu:
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients. | Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

TÀI LIỆU LIÊN QUAN

Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: A case–control study

Effects of statin use on volumetric mammographic density: Results from the KARMA study

Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: Impact on relative risk of breast cancer

Mammographic density in birth cohorts of Danish women: A longitudinal study

Mammographic density and inter-observer variability of pathologic evaluation of core biopsies among women with mammographic abnormalities

Evaluation of the association between quantitative mammographic density and breast cancer occurred in different quadrants

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer

Predictors of mammographic density among women with a strong family history of breast cancer

Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women

Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study